Coenzyme Q10

Short description: Biochemical cofactor and antioxidant

Coenzyme Q10

Names
Preferred IUPAC name

2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione

Other names

* In general: Ubiquinone, coenzyme Q, CoQ, vitamin Q (misnomer: being not required it cannot be a vitamin)
* This form: ubidecarenone,

Q10, CoQ10 /ˌkoʊˌkjuːˈtɛn/

Identifiers

CAS Number

* 303-98-0 Y

3D model (JSmol)

* Interactive image

ChEBI |

* CHEBI:46245 Y

ChEMBL |

* ChEMBL454801 Y

ChemSpider |

* 4445197 Y

KEGG |

* C11378

PubChem CID

* 5281915

UNII |

* EJ27X76M46 Y

InChI

* InChI=1S/C59H90O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61/h24,26,28,30,32,34,36,38,40,42H,15-23,25,27,29,31,33,35,37,39,41,43H2,1-14H3/b45-26+,46-28+,47-30+,48-32+,49-34+,50-36+,51-38+,52-40+,53-42+ Y

Key: ACTIUHUUMQJHFO-UPTCCGCDSA-N Y

* InChI=1/C59H90O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61/h24,26,28,30,32,34,36,38,40,42H,15-23,25,27,29,31,33,35,37,39,41,43H2,1-14H3/b45-26+,46-28+,47-30+,48-32+,49-34+,50-36+,51-38+,52-40+,53-42+

Key: ACTIUHUUMQJHFO-UPTCCGCDBK

SMILES

* O=C1/C(=C(\C(=O)C(\OC)=C1\OC)C)C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)C

Properties

Chemical formula

| C59H90O4
Molar mass | 863.365 g·mol−1
Appearance  | yellow or orange solid
Melting point |  48–52 °C (118–126 °F; 321–325 K)

Solubility in water

| insoluble
Pharmacology
1=ATC code }}  | C01EB09 (WHO)
Related compounds

Related quinones

| 1,4-Benzoquinone
Plastoquinone
Ubiquinol

Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Y verify (what is YN ?)
Infobox references

Coenzyme Q10 powder

Coenzyme Q (CoQ /ˌkoʊkjuː/), also known as ubiquinone, is a naturally occurring biochemical cofactor (coenzyme) and an antioxidant produced by the human body. The human body mainly produces the form known as coenzyme Q10 (CoQ10, ubidecarenone), but other forms exist.[1][2][3] CoQ is used by and found in many organisms, including animals and bacteria. As a result, it can also be obtained from dietary sources, such as meat, fish, seed oils, vegetables, and dietary supplements.[1][2]

CoQ plays a role in mitochondrial oxidative phosphorylation, aiding in the production of adenosine triphosphate (ATP), which is involved in energy transfer within cells.[1] The structure of CoQ10 consists of a benzoquinone moiety and an isoprenoid side chain, with the "10" referring to the number of isoprenyl chemical subunits in its tail.[4][5][6]

Although a ubiquitous molecule in human tissues, CoQ10 is not a dietary nutrient and does not have a recommended intake level, and its use as a supplement is not approved in the United States for any health or anti-disease effect.[1][2]

## Contents

* 1 Biological functions
* 2 Biochemistry
* 3 Deficiency
* 3.1 Assessment
* 3.2 Statins
* 4 Chemical properties
* 5 Biosynthesis
* 6 Dietary supplement
* 7 Regulation and composition
* 8 Research
* 9 Pharmacology
* 9.1 Absorption
* 9.2 Metabolism
* 9.3 Pharmacokinetics
* 9.4 Bioavailability
* 9.4.1 Reduction of particle size
* 9.4.2 Water-solubility
* 10 Adverse effects and precautions
* 11 Potential drug interactions
* 12 Dietary concentrations
* 12.1 Intake
* 12.2 Effect of heat and processing
* 13 History
* 14 See also
* 15 References

## Biological functions

See also: Biology:Q cycle

CoQ10 is a component of the mitochondrial electron transport chain (ETC), where it plays a role in oxidative phosphorylation, a process required for the biosynthesis of adenosine triphosphate, the primary energy source of cells.[1][6][7]

CoQ10 is a lipophilic molecule that is located in all biological membranes of the human body and serves as a component for the synthesis of ATP and is a life-sustaining cofactor for the three complexes (complex I, complex II, and complex III) of the ETC in the mitochondria.[1][5] CoQ10 has a role in the transport of protons across lysosomal membranes to regulate pH in lysosome functions.[1]

The mitochondrial oxidative phosphorylation process occurs in the inner mitochondrial membrane of eukaryotic cells.[1] This membrane is highly folded into structures called cristae, which increase the surface area available for oxidative phosphorylation. CoQ10 plays a role in this process as an essential cofactor of the ETC located in the inner mitochondrial membrane and serves the following functions:[1][7]

* electron transport in the mitochondrial ETC, by shuttling electrons from mitochondrial complexes like nicotinamide adenine dinucleotide (NADH), ubiquinone reductase (complex I), and succinate ubiquinone reductase (complex II), the fatty acids and branched-chain amino acids oxidation (through flavin-linked dehydrogenases) to ubiquinol–cytochrome-c reductase (complex III) of the ETC:[1][7] CoQ10 participates in fatty acid and glucose metabolism by transferring electrons generated from the reduction of fatty acids and glucose to electron acceptors;[8]
* antioxidant activity as a lipid-soluble antioxidant together with vitamin E, scavenging reactive oxygen species and protecting cells against oxidative stress,[1][6] inhibiting the oxidation of proteins, DNA, and use of vitamin E.[1][9]

## Biochemistry

Coenzyme Q (CoQ) is a quinone and functions as an electron carrier in the mitochondrial electron transport chain (ETC) of eukaryotes and many bacteria.[10] The other name for CoQ is ubiquinone which was assigned by the IUPAC-IUB Commission on Biochemical Nomenclature in 1975 due to its ubiquitous presence from bacteria to humans.[10] In humans the isoprene side chain has ten isoprene units, hence the abbreviation CoQ10.[10]

Coenzymes Q is a coenzyme family that is ubiquitous in animals and many Pseudomonadota,[11] a group of gram-negative bacteria. The fact that the coenzyme is ubiquitous gives the origin of its other name, ubiquinone.[1][2][12] In humans, the most common form of coenzymes Q is coenzyme Q10, also called CoQ10 (/ˌkoʊkjuːˈtɛn/) or ubiquinone-10.[1]

Coenzyme Q10 is a 1,4-benzoquinone, in which "Q" refers to the quinone chemical group and "10" refers to the number of isoprenyl chemical subunits (shown enclosed in brackets in the diagram) in its tail.[1] In natural ubiquinones, there are from six to ten subunits in the tail, with humans having a tail of 10 isoprene units (50 carbon atoms) connected to its benzoquinone "head".[1]

This family of fat-soluble substances is present in all respiring eukaryotic cells, primarily in the mitochondria.[1] Ninety-five percent of the human body's energy is generated this way.[13] Organs with the highest energy requirements—such as the heart, liver, and kidney—have the highest CoQ10 concentrations.[14][15][16][17]

There are three redox states of CoQ: fully oxidized (ubiquinone), semiquinone (ubisemiquinone), and fully reduced (ubiquinol).[1] The capacity of this molecule to act as a two-electron carrier (moving between the quinone and quinol form) and a one-electron carrier (moving between the semiquinone and one of these other forms) is central to its role in the electron transport chain due to the iron–sulfur clusters that can only accept one electron at a time and as a free radical–scavenging antioxidant.[1][12]

## Deficiency

There are two major pathways of deficiency of CoQ10 in humans: reduced biosynthesis, and increased use by the body.[18] Biosynthesis is the major source of CoQ10. Biosynthesis requires at least 15 genes, and mutations in any of them can cause CoQ deficiency.[18] CoQ10 levels also may be affected by other genetic defects (such as mutations of mitochondrial DNA, ETFDH, APTX, FXN, and BRAF, genes that are not directly related to the CoQ10 biosynthetic process).[18] Some of these, such as mutations in COQ6, can lead to serious diseases such as steroid-resistant nephrotic syndrome with sensorineural deafness.[19][20][21]

### Assessment

Although CoQ10 may be measured in blood plasma, these measurements reflect dietary intake rather than tissue status. Currently, most clinical centers measure CoQ10 levels in cultured skin fibroblasts, muscle biopsies, and blood mononuclear cells.[22] Culture fibroblasts can be used also to evaluate the rate of endogenous CoQ10 biosynthesis, by measuring the uptake of 14C-labeled p-hydroxybenzoate.[23]

CoQ10 is studied as an adjunctive therapy to reduce inflammation in periodontitis.[24]

### Statins

Although statins may reduce CoQ10 in the blood it is unclear if they reduce CoQ10 in muscle.[25] Evidence does not support that supplementation improves statin side effects.[25][26]

## Chemical properties

The oxidized structure of CoQ10 is shown below. The various kinds of coenzyme Q may be distinguished by the number of isoprenoid subunits in their side-chains. The most common coenzyme Q in human mitochondria is CoQ10.[1] Q refers to the quinone head and "10" refers to the number of isoprene repeats in the tail. The molecule below has three isoprenoid units and would be called Q3.

In its pure state, it is an orange-colored lipophile powder and has no taste or odor.[12]

## Biosynthesis

Biosynthesis occurs in most human tissue. There are three major steps:

1. Creation of the benzoquinone structure (using phenylalanine or tyrosine, via 4-hydroxybenzoate)
2. Creation of the isoprene side chain (using acetyl-CoA)
3. The joining or condensation of the above two structures

The initial two reactions occur in mitochondria, the endoplasmic reticulum, and peroxisomes, indicating multiple sites of synthesis in animal cells.[27]

An important enzyme in this pathway is HMG-CoA reductase, usually a target for intervention in cardiovascular complications. The "statin" family of cholesterol-reducing medications inhibits HMG-CoA reductase. One possible side effect of statins is decreased production of CoQ10, which may be connected to the development of myopathy and rhabdomyolysis. However, the role statins play in CoQ deficiency is controversial. Although statins reduce blood levels of CoQ, studies on the effects of muscle levels of CoQ are yet to come.

Genes involved include PDSS1, PDSS2, COQ2, and ADCK3 (COQ8, CABC1).[28]

Organisms other than humans produce the benzoquinone and isoprene structures from somewhat different source chemicals. For example, the bacteria E. coli produces the former from chorismate and the latter from a non-mevalonate source. The common yeast S. cerevisiae, however, derives the former from either chorismate or tyrosine and the latter from mevalonate. Most organisms share the common 4-hydroxybenzoate intermediate, yet again uses different steps to arrive at the "Q" structure.[29]

## Dietary supplement

Although neither a prescription drug nor an essential nutrient, CoQ10 is commonly used as a dietary supplement with the intent to prevent or improve disease conditions, such as cardiovascular disorders.[2][30] Despite its significant role in the body, it is not used as a drug to treat any specific disease.[1][2][3]

Nevertheless, CoQ10 is widely available as an over-the-counter dietary supplement and is recommended by some healthcare professionals, despite a lack of definitive scientific evidence supporting these recommendations,[1][3] especially when it comes to cardiovascular diseases.[31]

## Regulation and composition

CoQ10 is not approved by the U.S. Food and Drug Administration (FDA) for the treatment of any medical condition.[32][33][34][35] However, it is sold as a dietary supplement not subject to the same regulations as medicinal drugs, and is an ingredient in some cosmetics.[36] The manufacture of CoQ10 is not regulated, and different batches and brands may vary significantly.[34]

## Research

A 2014 Cochrane review found insufficient evidence to make a conclusion about its use for the prevention of heart disease.[37] A 2016 Cochrane review concluded that CoQ10 had no effect on blood pressure.[38] A 2021 Cochrane review found "no convincing evidence to support or refute" the use of CoQ10 for the treatment of heart failure.[39]

A 2017 meta-analysis of people with heart failure taking 30–100 mg/d of CoQ10 found a 31% lower mortality and increased exercise capacity, with no significant difference in the endpoints of left heart ejection fraction.[40] A 2021 meta-analysis found that CoQ10 was associated with a 31% lower all-cause mortality in HF patients.[41] In a 2023 meta-analysis of older people, ubiquinone had evidence of a cardiovascular effect, but ubiquinol (the reduced form) did not.[42]

Although CoQ10 has been studied as a potential remedy to treat purported muscle-related side effects of statin medications, the results were mixed. Although a 2018 meta-analysis concluded that there was preliminary evidence for oral CoQ10 reducing statin-associated muscle symptoms, including muscle pain, muscle weakness, muscle cramps, and muscle tiredness,[43] 2015[44] and 2024[31] meta-analysis found that CoQ10 had no effect on statin myopathy.[44][31]

## Pharmacology

### Absorption

CoQ10 in the pure form is a crystalline powder insoluble in water. Absorption as a pharmacological substance follows the same process as that of lipids; the uptake mechanism appears to be similar to that of vitamin E, another lipid-soluble nutrient.[17] This process in the human body involves secretion into the small intestine of pancreatic enzymes and bile, which facilitates emulsification and micelle formation required for absorption of lipophilic substances.[45] Food intake (and the presence of lipids) stimulates bodily biliary excretion of bile acids and greatly enhances absorption of CoQ10. Exogenous CoQ10 is absorbed from the small intestine and is best absorbed if taken with a meal. Serum concentration of CoQ10 in fed condition is higher than in fasting conditions.[46][47]

### Metabolism

CoQ10 is metabolized in all tissues, with the metabolites phosphorylated in cells.[2] CoQ10 is reduced to ubiquinol during or after absorption in the small intestine.[2] It is absorbed by chylomicrons, and redistributed in the blood within lipoproteins.[2] Its elimination occurs via biliary and fecal excretion.[2]

### Pharmacokinetics

Some reports have been published on the pharmacokinetics of CoQ10. The plasma peak can be observed 6–8 hours after oral administration when taken as a pharmacological substance.[2] In some studies, a second plasma peak was observed approximately 24 hours after administration, probably due to enterohepatic recycling and redistribution from the liver to circulation.[45]

Deuterium-labeled crystalline CoQ10 was used to investigate pharmacokinetics in humans to determine an elimination half-time of 33 hours.[48]

### Bioavailability

In contrast to the intake of CoQ10 as a constituent of food, such as nuts or meat, from which CoQ10 is normally absorbed, there is a concern about CoQ10 bioavailability when it is taken as a dietary supplement.[49][50] Bioavailability of CoQ10 supplements may be reduced due to the lipophilic nature of its molecule and large molecular weight.[49]

#### Reduction of particle size

Nanoparticles have been explored as a delivery system for various drugs, such as improving the oral bioavailability of drugs with poor absorption characteristics.[51] However, this has not proved successful with CoQ10, although reports have differed widely.[52]Cite error: Closing `</ref>` missing for `<ref>` tag

#### Water-solubility

Facilitating drug absorption by increasing its solubility in water is a common pharmaceutical strategy and also is successful for CoQ10. Various approaches have been developed to achieve this goal, with many of them producing significantly better results over oil-based soft gel capsules despite the many attempts to optimize their composition.[17] Examples of such approaches are use of the aqueous dispersion of solid CoQ10 with the polymer tyloxapol,[53] formulations based on various solubilising agents, such as hydrogenated lecithin,[54] and complexation with cyclodextrins; among the latter, the complex with β-cyclodextrin has been found to have highly increased bioavailability[55][56] and also is used in pharmaceutical and food industries for CoQ10-fortification.[17]

## Adverse effects and precautions

Generally, oral CoQ10 supplementation is well tolerated.[1] The most common side effects are gastrointestinal symptoms (nausea, vomiting, appetite suppression, and abdominal pain), rashes, and headaches.[57] Some adverse effects, largely gastrointestinal, are reported with intakes.[2] Doses of 100–300 mg per day may induce insomnia or elevate liver enzymes.[2] The observed safe level risk assessment method indicated that the evidence of safety is acceptable at intakes up to 1200 mg per day.[58]

Caution should be observed in the use of CoQ10 supplementation in people with bile duct obstruction and during pregnancy or breastfeeding.[2]

## Potential drug interactions

CoQ10 taken as a pharmacological substance has potential to inhibit the effects of theophylline as well as the anticoagulant warfarin; CoQ10 may interfere with warfarin's actions by interacting with cytochrome p450 enzymes thereby reducing the INR, a measure of blood clotting.[59] The structure of CoQ10 is similar to that of vitamin K, which competes with and counteracts warfarin's anticoagulation effects. CoQ10 is not recommended in people taking warfarin due to the increased risk of clotting.[57]

## Dietary concentrations

Detailed reviews on occurrence of CoQ10 and dietary intake were published in 2010.[60] Besides the endogenous synthesis within organisms, CoQ10 also is supplied by various foods.[1] CoQ10 concentrations in various foods are:[1]

CoQ10 levels in selected foods[60] Food | CoQ10 concentration (mg/kg)

|

Vegetable oils  | soybean oil | 54–280
olive oil | 40–160
grapeseed oil | 64–73
sunflower oil | 4–15
canola oil | 64–73
Beef  | heart | 113
liver | 39–50
muscle | 26–40
Pork  | heart | 12–128
liver | 23–54
muscle | 14–45
Chicken  | breast | 8–17
thigh  | 24–25
wing  | 11
Fish  | sardine | 5–64
mackerel – red flesh | 43–67
mackerel – white flesh | 11–16
salmon | 4–8
tuna | 5
Nuts | peanut | 27
walnut | 19
sesame seed | 18–23
pistachio | 20
hazelnut | 17
almond | 5–14
Vegetables  | parsley | 8–26
broccoli | 6–9
cauliflower | 2–7
spinach | up to 10
Chinese cabbage | 2–5
Fruit | avocado | 10
blackcurrant | 3
grape | 6–7
strawberry | 1
orange | 1–2
grapefruit | 1
apple | 1
banana | 1

Vegetable oils, meat, and fish are rich in CoQ10.[1] Dairy products are much poorer sources of CoQ10 than animal tissues. Among vegetables, broccoli and cauliflower are good sources of CoQ10.[1] Most fruits and berries are poor sources of CoQ10, except avocados, which have relatively high oil and CoQ10 content.[60]

### Intake

In the developed world, the estimated daily intake of CoQ10 has been determined at 3–6 mg per day, derived primarily from meat.[60]

South Koreans have an estimated average daily CoQ (Q9 \+ Q10) intake of 11.6 mg/d, derived primarily from kimchi.[61]

### Effect of heat and processing

Cooking by frying reduces CoQ10 content by 14–32%.[62]

## History

In 1950, a small amount of CoQ10 was isolated from the lining of a horse's gut, a compound initially called substance SA, but later deemed to be quinone found in many animal tissues.[63] In 1957, the same compound was isolated from mitochondrial membranes of beef heart, with research showing that it transported electrons within mitochondria. It was called Q-275 as a quinone.[63][64] The Q-275/substance SA was later renamed ubiquinone as it was a ubiquitous quinone found in all animal tissues.[63] In 1958, its full chemical structure was reported.[63][65] Ubiquinone was later called either mitoquinone or coenzyme Q due to its participation to the mitochondrial electron transport chain.[63] In 1966, a study reported that reduced CoQ6 was an effective antioxidant in cells.[66]

## See also

* Idebenone – synthetic analog with reduced oxidant-generating properties
* Mitoquinone mesylate – synthetic analog with improved mitochondrial permeability

## References

1. ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 1.22 1.23 1.24 1.25 1.26 "Coenzyme Q10". Micronutrient Information Center, Linus Pauling Institute, Oregon State University. 2018. https://lpi.oregonstate.edu/mic/dietary-factors/coenzyme-Q10.
2. ↑ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 2.12 2.13 "Coenzyme Q10". StatPearls, US National Library of Medicine. 30 January 2024. https://www.ncbi.nlm.nih.gov/books/NBK531491/.
3. ↑ 3.0 3.1 3.2 "Coenzyme Q10". National Center for Complementary and Integrative Health, US National Institutes of Health. January 2019. https://www.nccih.nih.gov/health/coenzyme-q10.
4. ↑ "Coenzyme Q10 Metabolism: A Review of Unresolved Issues". International Journal of Molecular Sciences 24 (3): 2585. January 2023. doi:10.3390/ijms24032585. PMID 36768907. This article incorporates text from this source, which is available under the CC BY 4.0 license.
5. ↑ 5.0 5.1 "The Impact of Coenzyme Q10 on Neurodegeneration: A Comprehensive Review". Current Pharmacology Reports 8: 1–19. 2022. doi:10.1007/s40495-021-00273-6.
6. ↑ 6.0 6.1 6.2 "Coenzyme Q10 and Immune Function: An Overview". Antioxidants 10 (5): 759. May 2021. doi:10.3390/antiox10050759. PMID 34064686. This article incorporates text from this source, which is available under the CC BY 4.0 license.
7. ↑ 7.0 7.1 7.2 "Coenzyme Q10 a mitochondrial restorer for various brain disorders". Naunyn Schmiedebergs Arch Pharmacol 394 (11): 2197–2222. November 2021. doi:10.1007/s00210-021-02161-8. PMID 34596729.
8. ↑ "Cellular Consequences of Coenzyme Q10 Deficiency in Neurodegeneration of the Retina and Brain". Int J Mol Sci 21 (23): 9299. December 2020. doi:10.3390/ijms21239299. PMID 33291255. This article incorporates text from this source, which is available under the CC BY 4.0 license.
9. ↑ "Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement". J Clin Med 9 (5): 1266. April 2020. doi:10.3390/jcm9051266. PMID 32349341. This article incorporates text from this source, which is available under the CC BY 4.0 license.
10. ↑ 10.0 10.1 10.2 Wang, Ying; Lilienfeldt, Noah; Hekimi, Siegfried (2024). "Understanding coenzyme Q". Physiological Reviews 104 (4): 1533–1610. doi:10.1152/physrev.00040.2023. PMID 38722242.
11. ↑ "Occurrence, biosynthesis and function of isoprenoid quinones". Biochimica et Biophysica Acta (BBA) – Bioenergetics 1797 (9): 1587–1605. September 2010. doi:10.1016/j.bbabio.2010.06.007. PMID 20599680. Bibcode: 2010BBAcB1797.1587N.
12. ↑ 12.0 12.1 12.2 This article incorporates public domain material from the National Center for Biotechnology Information website https://pubchem.ncbi.nlm.nih.gov/compound/5281915.
13. ↑ "Biochemical, physiological and medical aspects of ubiquinone function". Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease 1271 (1): 195–204. May 1995. doi:10.1016/0925-4439(95)00028-3. PMID 7599208.
14. ↑ "Human serum ubiquinol-10 levels and relationship to serum lipids". International Journal for Vitamin and Nutrition Research 59 (3): 288–292. 1989. PMID 2599795.
15. ↑ "Distribution and redox state of ubiquinones in rat and human tissues". Archives of Biochemistry and Biophysics 295 (2): 230–234. June 1992. doi:10.1016/0003-9861(92)90511-T. PMID 1586151.
16. ↑ "Enzymic and non-enzymic antioxidants in epidermis and dermis of human skin". The Journal of Investigative Dermatology 102 (1): 122–124. January 1994. doi:10.1111/1523-1747.ep12371744. PMID 8288904.
17. ↑ 17.0 17.1 17.2 17.3 "Improving the bioavailability of coenzyme q10 from theory to practice". Agro Food Industry Hi-Tech. 2008. https://www.scopus.com/inward/record.uri?eid=2-s2.0-53849139131&partnerID=40&md5=25ac2ff16eec9fc4a8b52430316bfbd8. Retrieved 5 April 2024.
18. ↑ 18.0 18.1 18.2 "Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency". J Inherit Metab Dis 38 (1): 145–56. January 2015. doi:10.1007/s10545-014-9749-9. PMID 25091424.
19. ↑ "COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness". Journal of Clinical Investigation 121 (5): 2013–2024. 2011. doi:10.1172/JCI45693. PMID 21540551.
20. ↑ "COQ6 mutation in patients with nephrotic syndrome, sensorineural deafness, and optic atrophy". JIMD Reports 54 (1): 37–44. 2020. doi:10.1002/jmd2.12068. PMID 32685349.
21. ↑ "Nephrotic Syndrome – COQ6 Associated (Concept Id: C4054393) – MedGen – NCBI". https://www.ncbi.nlm.nih.gov/medgen/886260.
22. ↑ "Coenzyme Q deficiency in muscle". Current Opinion in Neurology 24 (5): 449–456. October 2011. doi:10.1097/WCO.0b013e32834ab528. PMID 21844807.
23. ↑ "Analysis of coenzyme Q10 in muscle and fibroblasts for the diagnosis of CoQ10 deficiency syndromes". Clinical Biochemistry 41 (9): 697–700. June 2008. doi:10.1016/j.clinbiochem.2008.03.007. PMID 18387363.
24. ↑ "Can vitamins improve periodontal wound healing/regeneration?". Periodontol 2000 94 (1): 539–602. February 2024. doi:10.1111/prd.12513. PMID 37592831.
25. ↑ 25.0 25.1 "Coenzyme Q10 supplementation in the management of statin-associated myalgia". American Journal of Health-System Pharmacy 74 (11): 786–793. June 2017. doi:10.2146/ajhp160714. PMID 28546301.
26. ↑ Kennedy, Cormac; Köller, Yasmin; Surkova, Elena (1 April 2020). "Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis" (in en). Atherosclerosis 299: 1–8. doi:10.1016/j.atherosclerosis.2020.03.006. PMID 32179207.
27. ↑ "Coenzyme Q—biosynthesis and functions". Biochemical and Biophysical Research Communications 396 (1): 74–79. May 2010. doi:10.1016/j.bbrc.2010.02.147. PMID 20494114. Bibcode: 2010BBRC..396...74B.
28. ↑ Inherited Neuromuscular Diseases: Translation from Pathomechanisms to Therapies. Springer. 2009. pp. 122ff. ISBN 978-90-481-2812-9. https://books.google.com/books?id=uxQ_pjKNhE8C&pg=PA122. Retrieved 4 January 2011.
29. ↑ "Ubiquinone biosynthesis in microorganisms". FEMS Microbiology Letters 203 (2): 131–139. September 2001. doi:10.1111/j.1574-6968.2001.tb10831.x. PMID 11583838. Bibcode: 2001FEMML.203..131M.
30. ↑ "Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges". Comprehensive Reviews in Food Science and Food Safety 19 (2): 574–594. March 2020. doi:10.1111/1541-4337.12539. PMID 33325173.
31. ↑ 31.0 31.1 31.2 "Coenzyme Q10 for Enhancing Physical Activity and Extending the Human Life Cycle". Curr Med Chem 31 (14): 1804–1817. 2024. doi:10.2174/0929867330666230228103913. PMID 36852817.
32. ↑ This article incorporates public domain material from the National Cancer Institute website http://www.cancer.gov/cancertopics/pdq/cam/coenzymeQ10/patient.
33. ↑ ((PDQ Integrative, Alternative, and Complementary Therapies Editorial Board)) (2002). Coenzyme Q10: Health Professional Version. PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.
34. ↑ 34.0 34.1 This article incorporates public domain material from the National Cancer Institute website http://www.cancer.gov/cancertopics/pdq/cam/coenzymeQ10/HealthProfessional.
35. ↑ "Mitochondrial disorders in children: Co-enzyme Q10". UK: National Institute for Health and Care Excellence. 28 March 2017. https://www.nice.org.uk/advice/es11/resources/mitochondrial-disorders-in-children-coenzyme-q10-pdf-1158110303173.
36. ↑ "[Coenzyme Q10—its importance, properties and use in nutrition and cosmetics]". Ceska a Slovenska Farmacie 49 (3): 119–123. May 2000. PMID 10953455.
37. ↑ "Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease". The Cochrane Database of Systematic Reviews 2014 (12). 4 December 2014. doi:10.1002/14651858.CD010405.pub2. PMID 25474484.
38. ↑ "Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension". The Cochrane Database of Systematic Reviews 2016 (3). March 2016. doi:10.1002/14651858.CD007435.pub3. PMID 26935713.
39. ↑ "Coenzyme Q10 for heart failure". The Cochrane Database of Systematic Reviews 2021 (2). February 2021. doi:10.1002/14651858.CD008684.pub3. PMID 35608922.
40. ↑ "Efficacy of CoQ10 in patients with cardiac failure: a meta-analysis of clinical trials". BMC Cardiovascular Disorders 17 (1). July 2017. doi:10.1186/s12872-017-0628-9. PMID 28738783. This article incorporates text from this source, which is available under the CC BY 4.0 license.
41. ↑ Khan, Muhammad Shahzeb; Khan, Fiza; Fonarow, Gregg C.; Sreenivasan, Jayakumar; Greene, Stephen J.; Khan, Safi U.; Usman, Muhammad Shariq; Vaduganathan, Muthiah et al. (June 2021). "Dietary interventions and nutritional supplements for heart failure: a systematic appraisal and evidence map" (in en). European Journal of Heart Failure 23 (9): 1468–1476. doi:10.1002/ejhf.2278. ISSN 1388-9842. PMID 34173307. https://onlinelibrary.wiley.com/doi/10.1002/ejhf.2278. Retrieved 10 June 2024.
42. ↑ "Comparison of Coenzyme Q10 (Ubiquinone) and Reduced Coenzyme Q10 (Ubiquinol) as Supplement to Prevent Cardiovascular Disease and Reduce Cardiovascular Mortality". Current Cardiology Reports 25 (12): 1759–1767. December 2023. doi:10.1007/s11886-023-01992-6. PMID 37971634.
43. ↑ "Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials". Journal of the American Heart Association 7 (19). October 2018. doi:10.1161/JAHA.118.009835. PMID 30371340. This article incorporates text from this source, which is available under the CC BY 4.0 license.
44. ↑ 44.0 44.1 "Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials". Mayo Clinic Proceedings 90 (1): 24–34. January 2015. doi:10.1016/j.mayocp.2014.08.021. PMID 25440725.
45. ↑ 45.0 45.1 "Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics". Free Radical Research 40 (5): 445–453. May 2006. doi:10.1080/10715760600617843. PMID 16551570. Bibcode: 2006FdRR...40..445B.
46. ↑ "Biopharmaceutical aspects of intravenous and oral administration of coenzyme Q10.". Biomedical and clinical aspects of coenzyme Q. 6. 1991. pp. 215–224.
47. ↑ "Improvement in intestinal coenzyme q10 absorption by food intake". Yakugaku Zasshi 127 (8): 1251–1254. August 2007. doi:10.1248/yakushi.127.1251. PMID 17666877.
48. ↑ "Pharmacokinetic study of deuterium-labeled coenzyme Q10 in man". International Journal of Clinical Pharmacology, Therapy, and Toxicology 24 (10): 536–541. October 1986. PMID 3781673.
49. ↑ 49.0 49.1 "Bioavailability of Coenzyme Q10: An Overview of the Absorption Process and Subsequent Metabolism". Antioxidants 9 (5): 386. 2020. doi:10.3390/antiox9050386. PMID 32380795.
50. ↑ "Bioavailability and Sustained Plasma Concentrations of CoQ10 in Healthy Volunteers by a Novel Oral Timed-Release Preparation". Nutrients 11 (3): 527. 2019. doi:10.3390/nu11030527. PMID 30823449.
51. ↑ "Biologically erodable microspheres as potential oral drug delivery systems". Nature 386 (6623): 410–414. March 1997. doi:10.1038/386410a0. PMID 9121559. Bibcode: 1997Natur.386..410M.
52. ↑ "Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors". AAPS PharmSciTech 4 (3). 2003. doi:10.1208/pt040332. PMID 14621964.
53. ↑ Westesen K, Siekmann B, "Particles with modified physicochemical properties, their preparation and uses", US patent 6197349, published 2001
54. ↑ Ohashi H, Takami T, Koyama N, Kogure Y, Ida K, "Aqueous solution containing ubidecarenone", US patent 4483873, published 1984
55. ↑ "Relative bioavailability of two forms of a novel water-soluble coenzyme Q10". Annals of Nutrition & Metabolism 52 (4): 281–287. 2008. doi:10.1159/000129661. PMID 18645245.
56. ↑ "A Study on the Bioavailability of a Novel Sustained-Release Coenzyme Q10-β-Cyclodextrin Complex". Integrative Medicine 9 (1). 2010.
57. ↑ 57.0 57.1 "Coenzyme Q10: a therapy for hypertension and statin-induced myalgia?". Cleveland Clinic Journal of Medicine 77 (7): 435–442. July 2010. doi:10.3949/ccjm.77a.09078. PMID 20601617.
58. ↑ "Risk assessment for coenzyme Q10 (Ubiquinone)". Regulatory Toxicology and Pharmacology 45 (3): 282–288. August 2006. doi:10.1016/j.yrtph.2006.05.006. PMID 16814438.
59. ↑ "Coenzyme Q10 and Heart Failure: A State-of-the-Art Review". Circulation: Heart Failure 9 (4). April 2016. doi:10.1161/CIRCHEARTFAILURE.115.002639. PMID 27012265.
60. ↑ 60.0 60.1 60.2 60.3 "Coenzyme Q10 contents in foods and fortification strategies". Critical Reviews in Food Science and Nutrition 50 (4): 269–280. April 2010. doi:10.1080/10408390902773037. PMID 20301015.
61. ↑ "Ubiquinone contents in Korean fermented foods and average daily intakes". Journal of Food Composition and Analysis 24 (8): 1123–1129. 2011. doi:10.1016/j.jfca.2011.03.018.
62. ↑ "The coenzyme Q10 content of the average Danish diet". International Journal for Vitamin and Nutrition Research 67 (2): 123–129. 1997. PMID 9129255.
63. ↑ 63.0 63.1 63.2 63.3 63.4 "Ubiquinone". Nature 182 (4652): 1764–1767. December 1958. doi:10.1038/1821764a0. PMID 13622652. Bibcode: 1958Natur.182.1764M.
64. ↑ "Isolation of a quinone from beef heart mitochondria". Biochimica et Biophysica Acta 25 (1): 220–221. July 1957. doi:10.1016/0006-3002(57)90457-2. PMID 13445756.
65. ↑ "Coenzyme Q. I. structure studies on the coenzyme Q group". Journal of the American Chemical Society 80 (17): 4752. 1958. doi:10.1021/ja01550a096. ISSN 0002-7863. Bibcode: 1958JAChS..80.4752W.
66. ↑ "Quinones and quinols as inhibitors of lipid peroxidation". Lipids 1 (4): 282–284. July 1966. doi:10.1007/BF02531617. PMID 17805631.

* v
* t
* e

Metabolism: Citric acid cycle enzymes

Cycle|

* Citrate synthase
* Aconitase
* Isocitrate dehydrogenase
* Oxoglutarate dehydrogenase
* Succinyl CoA synthetase

* Succinate dehydrogenase (SDHA)
* Fumarase
* Malate dehydrogenase and ETC

Anaplerotic|

| to acetyl-CoA|

* Pyruvate dehydrogenase complex (E1, E2, E3)

* (regulated by Pyruvate dehydrogenase kinase and Pyruvate dehydrogenase phosphatase)

|

to α-ketoglutaric acid|

* Glutamate dehydrogenase

to succinyl-CoA|

* Methylmalonyl-CoA mutase

to oxaloacetate|

* Pyruvate carboxylase
* Aspartate transaminase

Mitochondrial
electron transport chain/
oxidative phosphorylation|

| Primary|

* Complex I/NADH dehydrogenase
* Complex II/Succinate dehydrogenase
* Coenzyme Q
* Complex III/Coenzyme Q - cytochrome c reductase
* Cytochrome c
* Complex IV/Cytochrome c oxidase

* Coenzyme Q10 synthesis: COQ2
* COQ3
* COQ4
* COQ5
* COQ6
* COQ7
* COQ9
* COQ10A
* COQ10B
* PDSS1
* PDSS2

|

Other|

* Alternative oxidase
* Electron-transferring-flavoprotein dehydrogenase

* v
* t
* e

Enzyme cofactors

Active forms|

| vitamins|

* TPP / ThDP (B1)
* FMN, FAD (B2)
* NAD+, NADH, NADP+, NADPH (B3)
* Coenzyme A (B5)
* PLP / P5P (B6)
* Biotin (B7)
* THFA / H4FA, DHFA / H2FA, MTHF (B9)
* AdoCbl, MeCbl (B12)
* Ascorbic acid (C)
* Phylloquinone (K1), Menaquinone (K2)
* Coenzyme F420

|

non-vitamins|

* ATP
* CTP
* SAMe
* PAPS
* GSH
* Coenzyme B
* Cofactor F430
* Coenzyme M
* Coenzyme Q
* Heme / Haem (A, B, C, O)
* Lipoic Acid
* Methanofuran
* Molybdopterin/Molybdenum cofactor
* PQQ
* THB / BH4
* THMPT / H4MPT

metal ions|

* Ca2+
* Cu2+
* Fe2+, Fe3+
* Mg2+
* Mn2+
* Mo
* Ni2+
* Zn2+

Base forms|

* vitamins: see vitamins

* v
* t
* e

Antioxidants

Food antioxidants|

* 6-Hydroxymelatonin
* Acetyl-L-carnitine (ALCAR)
* Alpha-lipoic acid (ALA)
* Ascorbic acid (vitamin C)
* Carotenoids (vitamin A)
* Curcumin
* Edaravone
* Polyphenols
* Glutathione
* Hydroxytyrosol
* L-carnitine
* Ladostigil
* Melatonin
* Mofegiline
* N-Acetylcysteine (NAC)
* N-Acetylserotonin (NAS)
* Oleocanthal
* Oleuropein
* Rasagiline
* Resveratrol
* Selegiline
* Selenium
* Tocopherols (vitamin E)
* Tocotrienols (vitamin E)
* Tyrosol
* Ubiquinone (coenzyme Q)
* Uric acid

Fuel antioxidants|

* Butylated hydroxytoluene
* 2,6-Di-tert-butylphenol
* 1,2-Diaminopropane
* 2,4-Dimethyl-6-tert-butylphenol
* Ethylenediamine

Measurements|

* Folin method
* ORAC
* TEAC
* FRAP

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Coenzyme Q10. Read more

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Coenzyme_Q10&oldid=4243837"
*[CID]: Compound ID
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template